Clinical Trials in Salt Lake City

Showing 4021-4040 of 16,694 trials

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

NCT05886894

The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix plus HydraGlyde Multifocal soft contact lenses in a real-world setting when worn as daily wear or extended (overnight) wear.

Refractive Errors

Alcon Research351 participantsStarted Aug 2023

San Diego, California, United States • Jacksonville, Florida, United States • Miami, Florida, United States +5 more locations

Active Not RecruitingNA< 1 mile

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

NCT05796453

The purpose of this Post-Market Clinical Follow-up study is to describe the long-term safety and performance of the Clareon Vivity and Vivity Toric and Clareon PanOptix and PanOptix Toric IOLs.

AphakiaAstigmatismPresbyopia

Alcon Research470 participantsStarted Sep 2023

Torrance, California, United States • Jacksonville, Florida, United States • Liverpool, New York, United States +4 more locations

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

Find Trials by Condition in Salt Lake City

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008)

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)

A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular Lenses

Lupus Landmark Study: A Prospective Registry and Biorepository

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours